by Midwestern Doctor, Lew Rockwell:
Prior to COVID-19, I considered Gardasil (for HPV) to be the most dangerous and unjustifiable vaccine on the market. It’s truly remarkable how many parallels can be found between it and the COVID-19 vaccines, so I feel it’s critically important for this already forgotten story to be told.
TRUTH LIVES on at https://sgtreport.tv/
The default strategy in medicine for any type of pain or injury is to throw NSAIDs at it—making the drugs immensely profitable. Unfortunately, they typically don’t help that much (which actually increases their sales since patients then need more of them), and they are fairly dangerous (e.g., NSAIDS kill tens of thousands of Americans each year and seriously injure far more—which is unfortunate since DMSO safely and effectively treats all the conditions NSAIDs are used for).
To create a new market, NSAIDs like Vioxx were created that were supposed to be safer…but also had a huge stroke and heart attack risk. However, despite evidence of harm continuing to mount, Merck and the FDA kept on covering it up, and when the drug was finally pulled, Vioxx was estimated to have killed 120,000 people. Sadly, as the FDA scientist who fought to get it off the market testified, this is business as usual, and another Vioxx disaster was inevitable.
Merck eventually had to pay a 5 billion Vioxx settlement (while the CEO received a $37.8 million “performance-based” bonus), leading Merck short of funds. This was solved by the decades of research finally yielding an HPV vaccine, which Merck (and the FDA) immediately went to work marketing through an “award-winning” advertising blitz that convinced every American they needed to be scared to death of cervical cancer (a fairly rare cancer).
It worked, with 25.1% of adolescent girls getting Gardasil in 2007, 53.8% by 2011, and by 2023, 79.3%. It was one of the most expensive vaccines on the market and quickly became a leading source of revenue for Merck (e.g., 1.87 billion in 2023). However, due to its cost (like the COVID vaccine), it required hefty government subsidies which included cash prizes to get the vaccine and a 40 million dollar HHS grant for developing the most effective sales script doctors could use to push the vaccine on “hesitant” patients.
Note: Because of its high cost, it frequently requires state or federal financial support for doctors to offer it (just like the COVID-19 vaccines).
The reason Merck had to aggressively market the fear of cervical cancer was that it was much less of a danger than it had been in the past, as it had largely been eliminated by interventions like pap smears.
Furthermore, its benefit for cervical cancer was entirely theoretical (Merck even convinced the FDA “studying cancer itself isn’t feasible, because it takes too long and it disadvantages too many women”) and despite 80% of women getting it, it still has not reduced cervical cancer:
Gardasl’s marketing also overshadowed the other two major risk factors for cervical cancer—smoking and birth control pills—have largely been overshadowed by the focus on HPV. Remarkably, the decline in smoking perfectly mirrors the decline in cervical cancer death:
Vaccines place the body under stress and divert the immune response to address the vaccine’s stimulus. If the immune system is already attempting to contain another infection, this can be quite problematic and allow the existing infection to spiral out of control. This phenomenon has been known about since 1893 and repeatedly demonstrated with many different infections (e.g., polio and typhus).
Originally Posted at https://www.sgtreport.com